H04.813
Granuloma of bilateral lacrimal passages
Clinical Classification Guidelines
Medical Intelligence & Overview
Granuloma of the bilateral lacrimal passages is a rare medical condition characterized by inflammatory growths or nodules forming within the tear duct passages on both sides of the face. These granulomas can interfere with normal tear drainage, leading to discomfort and other ocular issues. This condition is identified using the ICD-10 code H04.813 and involves complex immune responses that cause tissue swelling and inflammation within the tear drainage system.
Causes & Symptoms
Clinical Causes: Chronic inflammation due to infections or autoimmune responses Idiopathic factors, where the cause is unknown Previous trauma or injury to the eye or surrounding structures Foreign body reactions within the lacrimal passages Lacrimal duct obstruction leading to secondary granuloma formation
Key Symptoms: Persistent tearing or watering of the eyes (epiphora) Redness and swelling near the inner corner of the eye Discomfort or a feeling of fullness around the tear ducts Recurrent eye infections or discharge Possible blockage of tear drainage leading to tear retention Mild to moderate pain or tenderness in the affected area
Diagnostic & Treatment
Diagnosis Path: Evaluation typically involves a thorough eye examination by a healthcare professional, including inspection of the tear passages. Additional diagnostic procedures may include: - Dacryocystography (imaging of the tear ducts) - Nasolacrimal duct imaging such as dacryocystoscopy or MRI scans - Culture and sensitivity tests if an infection is suspected These assessments help confirm the presence of granulomas and determine their location and extent within the lacrimal passages.
Treatment Protocols: Management of granuloma of the bilateral lacrimal passages varies based on severity and underlying cause. Common treatment options include: - Medical therapy with anti-inflammatory medications or corticosteroids - Antibiotic therapy if an infection is present - Surgical procedures such as dacryocystorhinostomy (DCR) to create a new tear drainage pathway - Removal of granulomatous tissue if accessible and necessary - Addressing any underlying autoimmune or infectious conditions to prevent recurrence Continued follow-up with an eye specialist is essential for monitoring response to treatment and preventing complications.
Clinical Advice & FAQs
Billing Guidance
Is H04.813 a billable ICD-10 code?
Yes, H04.813 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H04.813?
Clinical documentation must specify the nature of Granuloma of bilateral lacrimal passages and any associated comorbidities for accurate reporting.
Cite this Clinical Reference